Ran Wang
Research Subjects
Ran Wang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Yi Zhun Zhu
School of Pharmacy and Laboratory of Drug Discovery from Natural Resources and Industrialization Macau University of Science and Technology Macau China
2 shared publications Zhaoyi Li
State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long, Taipa, China
2 shared publicationsHua Liu
Department of Pharmacy, Aerospace Center Hospital, Beijing, China
1 shared publicationJianchun Mao
Department of Rheumatology, Longhua Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication- Jianchun Mao
Shanghai University of Traditional Chinese Medicine, NO.1200 Cai Lun Road, Pudong New District, Shanghai, 201203, People's Republic of China
1 shared publication Jianghong Cai
State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long, Taipa, China
1 shared publication
Latest Publications
- Open Access
- 8 July 2022
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 7 (1) , 1-4
STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway
- 8 July 2022
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 7 (1) , 1-4
Open AccessSTAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway
- Open Access
- 1 April 2021
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (4) , e376
NAV2 positively modulates inflammatory response of fibroblast‐like synoviocytes through activating Wnt/β‐catenin signaling pathway in rheumatoid arthritis
- 1 April 2021
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (4) , e376
Open AccessNAV2 positively modulates inflammatory response of fibroblast‐like synoviocytes through activating Wnt/β‐catenin signaling pathway in rheumatoid arthritis